Biofrontera Inc.
BFRI
$1.08
-$0.02-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.71M | 37.17M | 39.19M | 38.00M | 37.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.71M | 37.17M | 39.19M | 38.00M | 37.32M |
| Cost of Revenue | 10.96M | 13.23M | 16.06M | 17.76M | 18.61M |
| Gross Profit | 30.74M | 23.94M | 23.13M | 20.24M | 18.72M |
| SG&A Expenses | 38.37M | 37.84M | 35.90M | 33.25M | 33.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.05M | 54.78M | 55.49M | 54.29M | 54.53M |
| Operating Income | -11.35M | -17.62M | -16.30M | -16.29M | -17.21M |
| Income Before Tax | -10.51M | -17.55M | -16.57M | -11.51M | -17.74M |
| Income Tax Expenses | 26.00K | 23.00K | 20.00K | 19.00K | 21.00K |
| Earnings from Continuing Operations | -10.54 | -17.57 | -16.59 | -11.53 | -17.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.54M | -17.57M | -16.59M | -11.53M | -17.76M |
| EBIT | -11.35M | -17.62M | -16.30M | -16.29M | -17.21M |
| EBITDA | -11.21M | -17.51M | -16.08M | -15.97M | -16.79M |
| EPS Basic | -1.18 | -1.84 | -2.21 | -1.69 | -4.10 |
| Normalized Basic EPS | -0.77 | -1.15 | -1.38 | -1.05 | -2.50 |
| EPS Diluted | -1.18 | -1.84 | -2.21 | -1.69 | -4.10 |
| Normalized Diluted EPS | -0.77 | -1.15 | -1.38 | -1.05 | -2.50 |
| Average Basic Shares Outstanding | 40.67M | 36.57M | 31.57M | 27.31M | 22.06M |
| Average Diluted Shares Outstanding | 40.67M | 36.57M | 31.57M | 27.31M | 22.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |